Mateon Therapeutics Inc (OTCQX US:MATN.PK)

Delayed Data
As of Feb 16
 +0.0201 / +9.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Mateon Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +316.58% increase from the last price of 0.24.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Mateon Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 38.46%
Growthannually 0.00%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.